Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_assertion type Assertion NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_head.
- NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_assertion description "[Primary (de novo) glioblastomas develop in older patients and are characterized by epidermal growth factor (EGF) receptor amplification/overexpression, p16 deletion, and PTEN mutations, whereas secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma develop in younger patients and frequently contain p53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_provenance.
- NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_assertion evidence source_evidence_literature NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_provenance.
- NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_assertion SIO_000772 10666371 NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_provenance.
- NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_assertion wasDerivedFrom befree-2016 NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_provenance.
- NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_assertion wasGeneratedBy ECO_0000203 NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_provenance.